Cellceutix has initiated the dose escalation of brilacidin (PMX-30063) in the second cohort of patients enrolled in a Phase 2 clinical trial evaluating the drug candidate for the treatment of ... Read more

The National Institutes of Health (NIH) awarded $10 million to a team of researchers in gastroenterology at Cedars-Sinai Medical Center in Los Angeles to conclude an ongoing research study investigating the ... Read more

A molecular-imaging drug developed at the University of New Mexico may radically change how inflammatory diseases and infections are diagnosed, creating the possibility of a non-invasive approach to detection. “This drug ... Read more

Patients with Crohn’s disease (CD) are at increased risk for developing thyroid cancer, although all inflammatory bowel disease patients show a “prevalence” for this cancer, a new study reports. The research, ... Read more

Protalix BioTherapeutics recently announced that the first patient has been enrolled in the Phase 2 clinical trial evaluating the safety, efficacy and properties of its lead drug candidate, OPRX-106, for ... Read more

Galapagos, a clinical-stage biotech specializing in small molecule medicines, has dosed its first patient in its DIVERSITY (NCT02914561) Phase 3 clinical trial of filgotinib in Crohn’s disease. The trial ... Read more

National Football League Buffalo Bills offensive tackle Seantrel Henderson, who has been diagnosed with Crohn’s disease, has been suspended for using marijuana, a violation of the NFL’s Policy and Program for ... Read more

Disclaimer:

IBD News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.